| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 Aug 24 | CGEM Cullinan Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 16.38 | 25,743 | 421.67 k | 25,743 |
| 13 Jun 24 | TRDA Entrada Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 16.45 | 16,000 | 263.20 k | 16,000 |
| 5 Jun 24 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Grant | Acquire A | No | No | 3.38 | 18,068 | 61.07 k | 18,068 |
| 3 May 24 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Grant | Acquire A | No | No | 3.03 | 13,928 | 42.20 k | 13,928 |
| 3 May 24 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Sale back to company | Dispose D | No | No | 10 | 13,928 | 139.28 k | 0 |
| 3 May 24 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Grant | Acquire A | No | No | 3.03 | 12,155 | 36.83 k | 12,155 |
| 3 May 24 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Sale back to company | Dispose D | No | No | 3.1 | 12,155 | 37.68 k | 0 |
| 3 May 24 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Grant | Acquire A | No | No | 3.03 | 24,309 | 73.66 k | 24,309 |
| 3 May 24 | VIGL Vigil Neuroscience | Stock Option Award Common Stock | Sale back to company | Dispose D | No | No | 6.8 | 24,309 | 165.30 k | 0 |
